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A b s t r A c t
A rare case of aggressive angiomyxoma (AAM) is reported here for its unusual presentation as a cervical polyp, in a 45‑year‑old 
woman. It is a soft tissue tumor. Preoperative diagnosis was uterine cervical polyp. Surgical excision was done. Histopathology 
examination revealed vascular, poorly circumscribed tumor mass composed of spindle cells embedded in myxoid stroma. In the 
reviewed literature, a single case of AAM mimicking cervical polyp has been reported. Our case may be the second rare case of 
AAM presenting as a cervical polyp.
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Aggressive angiomyxoma (AAM) was first described in 1983 
by Steeper and Rosai.[1] This mesenchymal tumor arises from 
connective tissue of lower pelvis or perineum and has a locally 
aggressive course.[2] The neoplasm predominantly affects 
reproductive age females with peak incidence during the 
third decade of life. The female to male ratio is 6:1. In women, 
vulvar region is the most common site of involvement.[3]
cAse RePORT
A 45-year-old female presented to Gynecology 
Out-patient-Department with complaints of something 
coming out of vagina since 2 months and yellowish discharge 
from the vagina since 15 days. Her menstrual cycles were 
regular. There was no pallor and icterus.
Systemic examination
P/A – Soft, nontender, no organomegaly was present. 
Per speculum examination showed 6 × 6 cm, polypoid, 
pedunculated, nontender mass arising from the posterior lip 
of cervix. Vaginal examination showed normal sized uterus. 
Hemogram was within normal limits. Patient was negative 
for human immunodeficiency virus (HIV) and hepatitis B 
surface antigen (HBsAg). Considering the clinical diagnosis 
of cervical polyp, excision was performed. Tumor mass 
was sent to pathology department for histopathological 
examination.
Gross pathology
On gross examination, the mass was polypoid, grayish-white, 
and soft to firm, measuring 6.5 × 5.5 × 4 cm [Figure 1]. 
The cut surface was slimy, gelatinous, and mostly solid with 
some cystic areas.
Microscopy
Sections revealed poorly circumscribed tumor mass, 
partly covered by ectocervical stratified squamous 
epithelium. The tumor mass was composed of spindle and 
stellate shaped cells with ill-defined cytoplasmic borders, 
numerous, variable sized thick muscular and thin walled 
blood vessels, embedded in the abundant myxoid stroma 
[Figures 2 and 3]. Occasional endocervical gland was also 
present, in the tumor mass. Cellular atypia was not seen. No 
cellular pleomorphism, anisonucleosis, increased mitotic 
activity, or necrosis were seen. No lipoblasts or nerve 
sheath elements were present. Histological diagnosis of 
AAM of cervix was given.
DIscUssIOn
AAM is a slowly growing myxoid neoplasm that occurs 
chiefly in the genital, perineal, and pelvic regions of adult 
women. The neoplasm predominantly affects reproductive 
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age females with peak incidence during the third decade of 
life. The female to male ratio is 6:1. In women vulvar region 
is the most common site of involvement.[3] In the reviewed 
literature, a rare case of AAM mimicking cervical polyp has 
been reported by Paplomata et al.[4] Our case may be the 
second such rare case of AAM presenting as a cervical polyp. 
Our patient was a 45-year-old female. Size of the tumor 
was more than 6 cm in diameter. The tumor presented as 
slowly growing, painless, polypoid, pedunculated mass. 
Microscopic examination showed poorly circumscribed 
tumor mass composed of variable sized thick and thin walled 
blood vessels, abundant myxoid stroma, and uniform bland 
spindle and stellate cells. Considering all these findings, 
histopathological diagnosis of aggressive angiomyxoma of 
cervix was given.
AAM must be distinguished from the more common benign 
and malignant myxoid tumors including myxoma, myxoid 
liposarcoma, myxoid neurofibroma, myxoid leiomyoma, 
leiomyosarcoma, myxoid liposarcoma, myxoid malignant 
fibrous histiocytoma, and botryoides rhabdomyosarcoma. 
AAM may also be clinically misdiagnosed as polyps, myxoma, 
lipoma, and Bartholin’s cyst of vagina. The diagnosis of 
angiomyxoma may be difficult to establish. The distinctively 
striking vascular component in AAM helps to rule out the 
above mentioned neoplasm as differential.[5]
In our tumor, histologically presence of striking vascular 
component and absence of nests of small basophilic cells 
(stromal cells) as well as absence of smooth muscle bundles 
helped to rule out myxoid variant of stromal tumor and 
myxoid leiomyoma, respectively.
In our case, considering the location of lesion, two close 
differential diagnoses were superficial angiomyxoma and 
angiomyofibroblastoma of cervix, which were ruled out 
histologically. Superficial angiomyxomas arise most often in 
the head and neck region and occasionally in the vulvovaginal 
region. They are slowly growing and circumscribed nodules. 
They are usually less than 3-4 cm in diameter. Histologically 
multiloculated, poorly delimited myxoid mass composed of 
plump spindle cells, numerous thin walled blood vessels, and 
inflammatory cells. Thick walled blood vessels are not seen 
in superficial angiomyxoma. These tumors have potential 
for local nondestructive recurrence in approximately 
30%	cases.[6]
Angiomyofibroblastomas are well circumscribed, round, 
ovoid, or lobulated, usually less than 3 cm in diameter. 
Majority of them measure 2-8 cm. The cut surface is 
gray-pink to yellowish-brown to tan. There are hyper 
and hypocellular areas. Perivascular hypercellularity is 
present. Epithelioid plump spindle cells, multinucleate 
cells, and many thin walled blood vessels are present. 
Figure 1: Gross specimen showing polypoid, pedunculated, glistening, 
grayish‑white tumor mass
Figure 3: Photomicrograph showing thick and thin walled blood vessels, 
in a myxoid stroma (H and E, ×100)
Figure 2: Photomicrograph showing blood vessels of variable caliber, in a 
myxoid stroma (H and E, ×100)
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Recurrence is rare.[3,6] Babala et al. reported a case of 
angiomyofibroblastoma of the cervix uteri. Recognition 
of this entity is important to avoid misdiagnosis of the 
other angiomyxoid neoplasms.[7]
Van Roggen et al. reported a clinicopathological and 
immunohistochemical study of 11 cases of AAM. All cases 
arising in females were positive for desmin, while three 
of the six cases arising in males were negative for desmin. 
Strong diffuse positivity for CDK4 was observed in all six 
cases. Six of eleven cases were positive for alpha smooth 
muscle antigen. Five of eleven were CD34 positive.[8] 
Skalova et al. described a rare case of AAM presenting as an 
endometrial uterine polyp. This was the first case of AAM 
within the uterine cavity.[9] Complete surgical excision is 
the gold standard for AAM because of its tendency to recur 
locally.	The	recurrence	rate	varies	from	36%	to	70%.	Surgery	
causes significant morbidity due to its frequent occurrence 
in lower pelvis and perineum with proximity to genitourinary 
and anorectal structures. Most surgeons aim at complete 
resection (wide excision with tumor free margin), 
incomplete or partial resection is acceptable when high 
operative morbidity is anticipated and fertility is an issue. 
Treatment options include use of hormonal manipulation 
such as tamoxifen, raloxifen or GnRH analogs, radiotherapy, 
and arterial embolization.[4,10]
It is typically a benign, nonmetastatizing neoplasm. In two 
cases, however, multiple metastasis have been reported.[11,12] 
Hence, long-term follow-up of patient is necessary. Our 
patient is followed up for 6 months after surgery. There is 
no evidence of recurrence till date.
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